DOCK6: Key Regulator of Cell-Cell Adhesion and Potential Drug Target Or Biomarker

Target Name: DOCK6

NCBI ID: G57572

DOCK6

DOCK6: Key Regulator of Cell-Cell Adhesion and Potential Drug Target Or Biomarker

DOCK6 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a key regulator of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs.

In recent years, researchers have been interested in DOCK6 because of its potential as a drug target or biomarker. Several studies have shown that DOCK6 plays a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of DOCK6 is its ability to interact with other proteins. This makes it a potential target for drugs that work by modulating the activity of other proteins. One class of drugs that are known to interact with DOCK6 are called small molecules that can modulate its activity by binding to specific residues on its surface.

Another promising aspect of DOCK6 is its involvement in cancer progression. Several studies have shown that DOCK6 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that DOCK6 may be a useful biomarker for these diseases, as well as for monitoring the effectiveness of cancer treatments.

In addition to its potential as a drug target or biomarker, DOCK6 is also of interest to researchers because of its role in cell-cell adhesion. This protein helps to regulate the stickiness of cells to each other, which is important for the formation of tissues and organs.

One of the challenges in studying DOCK6 is its complex structure. DOCK6 is a transmembrane protein, which means that it spans the cell membrane and is involved in the regulation of proteins that are on the same side of the membrane. This can make it difficult to study the protein's activity because it is constantly interacting with a variety of different proteins.

To overcome this challenge, researchers have used a variety of techniques to study DOCK6. One approach is to use antibodies to tag the protein and study its activity in cell culture or animal models. This has allowed researchers to determine the protein's effects on cell-cell adhesion, as well as its potential as a drug target or biomarker.

Another approach is to study the protein's activity in live animals. This has allowed researchers to see how the protein's activity changes in response to different conditions, such as the presence of drugs or exposure to toxins.

In addition to its potential as a drug target or biomarker, DOCK6 is also of interest to researchers because of its role in the regulation of cell-cell adhesion. This protein helps to regulate the stickiness of cells to each other, which is important for the formation of tissues and organs.

One of the challenges in studying DOCK6 is its complex structure. DOCK6 is a transmembrane protein, which means that it spans the cell membrane and is involved in the regulation of proteins that are on the same side of the membrane. This can make it difficult to study the protein's activity because it is constantly interacting with a variety of different proteins.

To overcome this challenge, researchers have used a variety of techniques to study DOCK6. One approach is to use antibodies to tag the protein and study its activity in cell culture or animal models. This has allowed researchers to determine the protein's effects on cell-cell adhesion, as well as its potential as a drug target or biomarker.

Another approach is to study the protein's activity in live animals. This has allowed researchers to see how the protein's activity changes in response to different conditions, such as the presence of drugs or exposure to toxins.

In addition to its potential as a drug target or biomarker, DOCK6 is also of interest to researchers because of its role in the regulation of cell-cell adhesion. This protein helps to regulate the stickiness of cells to each other, which is important for the formation of tissues and organs.

Overall, DOCK6 is a protein that is

Protein Name: Dedicator Of Cytokinesis 6

Functions: Acts as guanine nucleotide exchange factor (GEF) for CDC42 and RAC1 small GTPases. Through its activation of CDC42 and RAC1, may regulate neurite outgrowth (By similarity)

The "DOCK6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DOCK6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets